Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark G Lebwohl

Showing results (101-110 of 209) with videos related to

Pageof 21
Sort By:
Journal of Drugs in Dermatology : JDD|August 27, 2020
The Effect of Tildrakizumab on Cardiometabolic Risk Factors in Psoriasis by Metabolic Syndrome Status: Post Hoc Analysis of Two Phase 3 Trials (ReSURFACE 1 and ReSURFACE 2)M Alan Menter, Nehal N Mehta, Mark G Lebwohl, et al.
Journal of Drugs in Dermatology : JDD|March 4, 2026
Expert Consensus on Advanced Topical Nonsteroidal Therapies for Chronic Hand EczemaApril W Armstrong, Yvonne Nong, Christopher G Bunick, et al.
Journal of Drugs in Dermatology : JDD|March 4, 2026
Brodalumab's 8-Year Journey in Plaque Psoriasis: Insights into Efficacy, Safety, and Real-World EvidenceMark G Lebwohl, James G Krueger, John Y Koo, et al.
Journal of the American Academy of Dermatology|December 24, 2008
Treatment of intertriginous psoriasis: from the Medical Board of the National Psoriasis FoundationRobert E Kalb, Jerry Bagel, Neil J Korman, et al.
The Journal of Nutrition|November 11, 2003
Isoflavone genistein: photoprotection and clinical implications in dermatologyHuachen Wei, Rao Saladi, Yuhun Lu, et al.
Journal of the American Academy of Dermatology|May 22, 2012
Treatment of pustular psoriasis: from the Medical Board of the National Psoriasis FoundationAmanda Robinson, Abby S Van Voorhees, Sylvia Hsu, et al.
Journal of the American Academy of Dermatology|May 20, 2008
National Psoriasis Foundation consensus statement on screening for latent tuberculosis infection in patients with psoriasis treated with systemic and biologic agentsSean D Doherty, Abby Van Voorhees, Mark G Lebwohl, et al.
Journal of Drugs in Dermatology : JDD|March 11, 2026
Advanced Topical Nonsteroidal Therapies for Atopic Dermatitis: Consensus Statements from an Expert PanelApril W Armstrong, Yvonne Nong, Christopher G Bunick, et al.
Dermatology and Therapy|September 16, 2024
Impact of Disease Factors of Patients with Psoriasis and Psoriatic Arthritis on Biologic Therapy Switching: Real-World Evidence from the CorEvitas Psoriasis RegistryPhilip J Mease, Andrew Blauvelt, Adam P Sima, et al.
Journal of the American Academy of Dermatology|August 10, 2010
Obesity and psoriasis: from the Medical Board of the National Psoriasis FoundationSamuel Bremmer, Abby S Van Voorhees, Sylvia Hsu, et al.
Pageof 21

Showing results (101-110 of 209) with videos related to

Sort By:
Pageof 21
Journal of Drugs in Dermatology : JDD|August 27, 2020
The Effect of Tildrakizumab on Cardiometabolic Risk Factors in Psoriasis by Metabolic Syndrome Status: Post Hoc Analysis of Two Phase 3 Trials (ReSURFACE 1 and ReSURFACE 2)M Alan Menter, Nehal N Mehta, Mark G Lebwohl, et al.
Journal of Drugs in Dermatology : JDD|March 4, 2026
Expert Consensus on Advanced Topical Nonsteroidal Therapies for Chronic Hand EczemaApril W Armstrong, Yvonne Nong, Christopher G Bunick, et al.
Journal of Drugs in Dermatology : JDD|March 4, 2026
Brodalumab's 8-Year Journey in Plaque Psoriasis: Insights into Efficacy, Safety, and Real-World EvidenceMark G Lebwohl, James G Krueger, John Y Koo, et al.
Journal of the American Academy of Dermatology|December 24, 2008
Treatment of intertriginous psoriasis: from the Medical Board of the National Psoriasis FoundationRobert E Kalb, Jerry Bagel, Neil J Korman, et al.
The Journal of Nutrition|November 11, 2003
Isoflavone genistein: photoprotection and clinical implications in dermatologyHuachen Wei, Rao Saladi, Yuhun Lu, et al.
Journal of the American Academy of Dermatology|May 22, 2012
Treatment of pustular psoriasis: from the Medical Board of the National Psoriasis FoundationAmanda Robinson, Abby S Van Voorhees, Sylvia Hsu, et al.
Journal of the American Academy of Dermatology|May 20, 2008
National Psoriasis Foundation consensus statement on screening for latent tuberculosis infection in patients with psoriasis treated with systemic and biologic agentsSean D Doherty, Abby Van Voorhees, Mark G Lebwohl, et al.
Journal of Drugs in Dermatology : JDD|March 11, 2026
Advanced Topical Nonsteroidal Therapies for Atopic Dermatitis: Consensus Statements from an Expert PanelApril W Armstrong, Yvonne Nong, Christopher G Bunick, et al.
Dermatology and Therapy|September 16, 2024
Impact of Disease Factors of Patients with Psoriasis and Psoriatic Arthritis on Biologic Therapy Switching: Real-World Evidence from the CorEvitas Psoriasis RegistryPhilip J Mease, Andrew Blauvelt, Adam P Sima, et al.
Journal of the American Academy of Dermatology|August 10, 2010
Obesity and psoriasis: from the Medical Board of the National Psoriasis FoundationSamuel Bremmer, Abby S Van Voorhees, Sylvia Hsu, et al.
Pageof 21